Pfizer Inc. (PFE)

Compare

25.21

+0.20

+(0.80%)

At close: March 28 at 4:00:02 PM EDT

25.13

-0.08

(-0.34%)

After hours: March 28 at 7:59:48 PM EDT

Pfizer Inc. (PFE): Among Blue Chip Stocks to Invest in at 52-Week Lows

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other blue chip stocks to invest in at 52-week lows. For the first time since 2023, the S&P 500 was seen in […]

Insider Monkey 17 hours ago

PFE
+0.80%
Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks

Instead of staying on the sidelines, I like to put my money to work when the stock market is bumpy. Here's why I recently bought these three ultra-high-yield dividend stocks amid the current choppiness. The reality is that even if Ares Capital's share price goes nowhere, I'll still enjoy a pretty good return thanks to the dividend alone.

Motley Fool yesterday

ARCC

ET

PFE
+0.80%
Genmab’s Tivdak approved in Japan for advanced cervical cancer

The approval is based on open-label Phase III innovaTV 301 clinical trial data.

Pharmaceutical Technology 2 days ago

GMAB.CO

PFE
+0.80%
Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks were higher late Thursday afternoon, with the NYSE Health Care Index up 0.3% and

PREMIUM
MT Newswires 3 days ago

PFE
+0.80%
WBA

RGLS
Update: Sen. Ron Wyden Accuses Pfizer of Tax Dodging After Concluding Investigation

(Update with Pfizer's response to a request for comment.) Pfizer (PFE) sold $20 billion of drugs

PREMIUM
MT Newswires 3 days ago

PFE
+0.80%
Pfizer Is Facing A First-Quarter Slowdown. Is Pfizer Stock Now A Sell?

Is Pfizer stock a sell now with expectations for first-quarter sales and earnings to slide? Is PFE stock now a sell?

Investor's Business Daily 3 days ago

PFE
+0.80%
Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive

The European Commission approves MRK's pneumococcal 21-valent conjugate vaccine, Capvaxive, for pneumococcal vaccination in adults.

Zacks 3 days ago

SNY

PFE
+0.80%
GSK accuses Pfizer of delaying Covid vaccine result until after US election

Donald Trump’s justice department is investigating claims that Pfizer delayed positive news about its Covid-19 vaccine until after the 2020 election.

The Telegraph 3 days ago

PFE
+0.80%
BNTX
Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals?

With its stock down 5.4% over the past month, it is easy to disregard Pfizer (NYSE:PFE). We, however decided to study...

Simply Wall St. 3 days ago

PFE
+0.80%
Update: Market Chatter: US Prosecutors Investigate Tip on Pfizer Vaccine

(Updates with Pfizer's response to a request for comment from MT Newswires in the second and third p

PREMIUM
MT Newswires 3 days ago

PFE
+0.80%
Why Pfizer Is My Largest Healthcare Position

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point.

Motley Fool 3 days ago

PFE
+0.80%
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers.

StockStory 3 days ago

PFE
+0.80%
SUPN

ZTS
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against Covid-19 until after the election that Trump lost to Biden.

The Wall Street Journal 4 days ago

GLAXF

GSK

PFE
+0.80%
Here's Why Pfizer (PFE) Fell More Than Broader Market

In the latest trading session, Pfizer (PFE) closed at $25.21, marking a -1.33% move from the previous day.

Zacks 4 days ago

PFE
+0.80%
Pfizer Stock Slips After Report on Vaccine Timing Probe

Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion that the pharmaceutical giant delayed announcing a successful Covid-19 vaccine until after the 2020 election.

The Wall Street Journal 4 days ago

PFE
+0.80%
ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce that APRETUDE (cabotegravir tablets and extended release injectable suspension) is now covered under the federal Non-Insured Health Benefits (NIHB) Program for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at risk individuals who are HIV-1 negative.1

CNW Group 4 days ago

PFE
+0.80%
GLAXF

GSK
Pfizer: Undervalued Defensive Play

Undervalued, Strong Pipeline, Positioned for Growth Potential.

GuruFocus.com 5 days ago

PFE
+0.80%
5 Large Drug Stocks to Watch as Industry Recovers

R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo Nordisk (NVO), Novartis (NVS), Pfizer (PFE) and Bayer (BAYRY) are worth retaining in one's portfolio

Zacks 5 days ago

ABBV

PFE
+0.80%
NVS
Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day

Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day

Zacks 6 days ago

PFE
+0.80%
CCI

AVGO
Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds?

We recently published a list of 14 Best Affordable Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best affordable stocks to invest in. The broader market has taken a significant hit, dropping 10% from its peak and wiping […]

Insider Monkey 6 days ago

PFE
+0.80%

Performance Overview

Return	PFE	S&P 500 (^GSPC)
YTD	-3.40%	-5.11%
1-Year	-3.46%	+6.22%
3-Year	-45.33%	+21.97%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Pfizer Inc. (PFE)

Pfizer Inc. (PFE): Among Blue Chip Stocks to Invest in at 52-Week Lows

Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks

Genmab’s Tivdak approved in Japan for advanced cervical cancer

Sector Update: Health Care Stocks Advance Late Afternoon

Update: Sen. Ron Wyden Accuses Pfizer of Tax Dodging After Concluding Investigation

Pfizer Is Facing A First-Quarter Slowdown. Is Pfizer Stock Now A Sell?

Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive

GSK accuses Pfizer of delaying Covid vaccine result until after US election

Is Pfizer Inc.'s (NYSE:PFE) Recent Price Movement Underpinned By Its Weak Fundamentals?

Update: Market Chatter: US Prosecutors Investigate Tip on Pfizer Vaccine

Why Pfizer Is My Largest Healthcare Position

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine

Here's Why Pfizer (PFE) Fell More Than Broader Market

Pfizer Stock Slips After Report on Vaccine Timing Probe

ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

Pfizer: Undervalued Defensive Play

5 Large Drug Stocks to Watch as Industry Recovers

Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day

Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds?

Performance Overview